Takeda Pharmaceutical
TAK
#481
Rank
$47.81 B
Marketcap
$14.37
Share price
0.77%
Change (1 day)
9.19%
Change (1 year)

Takeda Pharmaceutical (TAK) - Cash on Hand

Cash on Hand as of September 2025 : $4.99 Billion USD

According to Takeda Pharmaceutical's latest financial reports the company has $4.99 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Takeda Pharmaceutical - Cash on Hand chart (from 2008 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-03-31$2.70 B-13.38%
2024-03-31$3.12 B-24.78%
2023-03-31$4.15 B-42.22%
2022-03-31$7.18 B-20.63%
2021-03-31$9.05 B48.98%
2020-03-31$6.07 B-6.99%
2019-03-31$6.53 B85.19%
2018-03-31$3.52 B4.39%
2017-03-31$3.38 B-32.1%
2016-03-31$4.97 B-16.24%
2015-03-31$5.94 B-27.91%
2014-03-31$8.24 B38.37%
2013-03-31$5.95 B7.23%
2012-03-31$5.55 B-47.01%
2011-03-31$10.48 B11.44%
2010-03-31$9.41 B22.37%
2009-03-31$7.69 B-53.31%
2008-03-31$16.47 B7.77%
2007-03-31$15.28 B-3.69%
2006-03-31$15.87 B12.25%
2005-03-31$14.13 B11.3%
2004-03-31$12.70 B31.09%
2003-03-31$9.68 B45.76%
2002-03-31$6.64 B16.37%
2001-03-31$5.71 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
$18.56 B 271.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$10.45 B 109.12%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
$14.98 B 199.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$9.75 B 95.14%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
$1.23 B-75.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
$0.78 B-84.28%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
$9.44 B 88.98%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
$4.44 B-11.08%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
$18.21 B 264.43%๐Ÿ‡บ๐Ÿ‡ธ USA